Prognostic significance of morphological assessment of plasma cells in multiple myeloma release_7dd6fxdxsbecbpkmdixuy6yqqu

by M. AL-SAHMANI, I. TRNAVSKA, S. SEVCIKOVA, L. ANTOSOVA, J. KISSOVA, Z. ADAM, L. POUR, P. NEMEC, H. GRESLIKOVA, M. KREJCI, L. ZAHRADOVA, A. BULIKOVA (+2 others)

Cited By

References to this release by other works.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 4 of 4 references (in 83ms)

via crossref
Plasma cell leukemia: from biology to treatment
Tomas Jelinek, Fedor Kryukov, Lucie Rihova, Roman Hajek
2015   European Journal of Haematology
doi:10.1111/ejh.12533  pmid:25778450 

via crossref
Plasma cell morphology in multiple myeloma and related disorders
B. Ribourtout, M. Zandecki
2015   Morphologie
doi:10.1016/j.morpho.2015.02.001  pmid:25899140 

via crossref
Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1
Hua Jiang, Jianfeng Zou, Hui Zhang, Weijun Fu, Tianmei Zeng, Hejing Huang, Fan Zhou, Jian Hou
2013   Clinical and Experimental Medicine (Testo stampato)
doi:10.1007/s10238-013-0269-y  pmid:24356728 

via crossref
CXCR4 is a good survival prognostic indicator in multiple myeloma patients
Li Bao, Yueyun Lai, Yanrong Liu, Yazhen Qin, Xiaosu Zhao, Xijing Lu, Qian Jiang, Jin Lu (+ more)
2013   Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis
doi:10.1016/j.leukres.2013.06.002  pmid:23849988